Bullens, Sherry,Bunting, Stuart,Chou, Tianwei,Okhamafe, Augustus O.,Price, Christopher P.,Went, Daniel J.,Yap, Clarence
申请号：
AU2016298425
公开号：
AU2016298425A1
申请日:
2016.08.01
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The present disclosure provides for use of variants of C-type natriuretic peptide (CNP), and novel pharmaceutical compositions and formulations comprising CNP variant peptides for the treatment of skeletal dysplasias, one or more symptoms of skeletal dysplasias, such as long bone growth or growth velocity, and other disorders having a skeletal dysplasia and/or CNP-associated symptom or component.
